1. Home
  2. ACIC vs MAZE Comparison

ACIC vs MAZE Comparison

Compare ACIC & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIC
  • MAZE
  • Stock Information
  • Founded
  • ACIC 1999
  • MAZE 2018
  • Country
  • ACIC United States
  • MAZE United States
  • Employees
  • ACIC N/A
  • MAZE N/A
  • Industry
  • ACIC Property-Casualty Insurers
  • MAZE
  • Sector
  • ACIC Finance
  • MAZE
  • Exchange
  • ACIC Nasdaq
  • MAZE NYSE
  • Market Cap
  • ACIC 611.7M
  • MAZE 523.1M
  • IPO Year
  • ACIC N/A
  • MAZE 2025
  • Fundamental
  • Price
  • ACIC $11.57
  • MAZE $11.01
  • Analyst Decision
  • ACIC Buy
  • MAZE Strong Buy
  • Analyst Count
  • ACIC 1
  • MAZE 3
  • Target Price
  • ACIC $16.00
  • MAZE $25.67
  • AVG Volume (30 Days)
  • ACIC 162.4K
  • MAZE 266.1K
  • Earning Date
  • ACIC 05-08-2025
  • MAZE 01-01-0001
  • Dividend Yield
  • ACIC 4.31%
  • MAZE N/A
  • EPS Growth
  • ACIC N/A
  • MAZE N/A
  • EPS
  • ACIC 1.54
  • MAZE 1.25
  • Revenue
  • ACIC $296,657,000.00
  • MAZE $167,500,000.00
  • Revenue This Year
  • ACIC $6.93
  • MAZE N/A
  • Revenue Next Year
  • ACIC $8.36
  • MAZE N/A
  • P/E Ratio
  • ACIC $7.55
  • MAZE $8.81
  • Revenue Growth
  • ACIC 12.20
  • MAZE N/A
  • 52 Week Low
  • ACIC $8.82
  • MAZE $9.88
  • 52 Week High
  • ACIC $15.08
  • MAZE $17.00
  • Technical
  • Relative Strength Index (RSI)
  • ACIC 41.96
  • MAZE N/A
  • Support Level
  • ACIC $11.35
  • MAZE N/A
  • Resistance Level
  • ACIC $12.19
  • MAZE N/A
  • Average True Range (ATR)
  • ACIC 0.40
  • MAZE 0.00
  • MACD
  • ACIC -0.04
  • MAZE 0.00
  • Stochastic Oscillator
  • ACIC 19.64
  • MAZE 0.00

About ACIC American Coastal Insurance Corporation

American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.

About MAZE MAZE THERAPEUTICS INC

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Share on Social Networks: